Endokrinoloji ve dermatoloji

Normal ergenlik sürecinde ve bazı endokrin hastalıkların seyri sırasında deri etkilenir. Deri bulguları altta yatan hastalığın ilk belirtisi olabilir, bu hastalıkla aynı görülebilir veya daha sonra ortaya çıkabilir. Bu yazıda, fizyolojik ve patolojik durumlarda görülebilen deri bulguları gözden geçirildi. (Güncel Pediatri 2011; 9: 34-8)

Endocrinology and dermatology

The skin is affected during normal pubertal development and the progression of a number of endocrine diseases. The skin manifestations may precede an underlying endocrine disease, may emerge simultaneously with the associated disease or may become apparent after the endocrine condition is diagnosed. In this paper, we will review the skin findings associated with physiologic and pathologic endocrine conditions. (Journal of Current Pediatrics 2011; 9: 34-8)

PDF

___

1. Fine JD, Nasır A, Becker KL. The skin and endocrine disorders. In: Becker KL, ed. Principles and Practice of Endocrinology and Metabolism. Philadelphia: Lippincott Williams & Wilkins, 2001: 1991-2001.
2. Costello MJ. Eruptions of pregnancy. NY State J Med 1941;41:849-57.
3. Lang PC. Cutaneous manifestations of thyroid disease. Cutis 1978;21:862-79.
4. Pujol RM, Monmany J, Bague S, Alomar A. Graves disease presenting as localized myxedematous infiltration in a smallpox vaccination scar. Clin Exp Dermatol 2000;25:132-4.
5. DePadova-Elder SM, Ditre CM, Kantor GR, Koblenzer PJ. Candidiasis endocrinopathy syndrome. Aerch Dermatol 1994;130:19-22.
6. Carney JA, Gordon H, Carpenter PC, Shenoy BV, Go VL. The complex of myxomas, spotty pigmentation and endocrine overactivity. Medicine (Baltimore) 1985;64:270-83.
7. Watson JC, Stratakis CA, Bryant-Greenwood PK, Koch CA, Kirschner LS, Nguyen T, et al. Neurosurgical implications of Carney complex. J Neurosurg 2000;92:413-8.
8. Kahan RS, Perez-Figaredo RA, Neimanis A. Necrolytic migratory erythema. Distinctive dermatosis of the glucagonoma syndrome. Arch Dermatol 1977;113:792-7.
9. Bassett ML, Halliday JW, Powell LW. Hemochromatosis-newer concepts: diagnosis and management. Dis Mon 1980;26:1-44.
10. Matsuoka LY, Wortsman J, Gavin JR, Goldman J. Spectrum of endocrine abnormalities associated with acanthosis nigricans. Am J Med 1987;83:719-25.
11. Darling TN, Skarulis MC, Steinberg SM, Marx SJ, Spiegel AM, Turner M. Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1. Arch Derm 1997;133:853-7.
12. Pack S, Turner ML, Zhuang Z, Vortmeyer AO, Böni R, Skarulis M et al. Cutaneous tumors in patients with multiple endocrine neoplasia type 1 show allelic deletion of the MEN1 gene. J Invest Derm 1998;110:438-40.
13. Mehregan DA, Winkelmann RK. Cutaneous gangrene, vascular calcification, and hyperparathyroidism. Mayo Clin Proc 1989;64:211-5.
14. Angelis M, Wong LL, Myers SA, Wong LM. Calciphylaxis in patients on hemodialysis: a prevalence study. Surgery 1997;122:1089-90.
15. Hofman KJ. Diffusion of information about neurofibromatosis type 1. DNA Testing. Am J Med Genet 1994;49:299-301.
16. Martuza RL. Eldridge R. Neurofibromatosis 2 (bilateral acoustic neurofibromatosis). N Engl J Med 1988;318:684-8.
17. Goldsmith LA. Tyrosine-induced skin disease. Br J Dermatol 1978;98:119-23.
18. Fine JD, Wise TG, Falchuk KH. Zinc in cutaneous disease and dermatologic therapeutics. In: Moschella SL. Ed. Dermatology update: reviews for physicians. New York: Elsevier, 1982:299-312.
19. Bech-Thomsen N, Angelo HR, Wulf HC. Skin pigmentation as a predictor of minimal phototoxic dose after oral methoxsalen. Arch Dermatol 1994;130:464-8.
20. Schulz W, Domenico D, Nand S. POEMS syndrome associated with polycythemia vera. Cancer 1989;63:1175-8.